PharVision Advisers LLC Invests $300,000 in Itron, Inc. $ITRI

PharVision Advisers LLC acquired a new position in shares of Itron, Inc. (NASDAQ:ITRI) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 2,859 shares of the scientific and technical instruments company’s stock, valued at approximately $300,000.

Several other large investors also recently modified their holdings of the stock. Wayfinding Financial LLC acquired a new stake in Itron in the 1st quarter valued at $45,000. CoreCap Advisors LLC grew its position in Itron by 25.5% in the 4th quarter. CoreCap Advisors LLC now owns 616 shares of the scientific and technical instruments company’s stock valued at $67,000 after purchasing an additional 125 shares during the period. Quarry LP grew its position in Itron by 155.6% in the 1st quarter. Quarry LP now owns 910 shares of the scientific and technical instruments company’s stock valued at $95,000 after purchasing an additional 554 shares during the period. Contravisory Investment Management Inc. grew its position in Itron by 98.0% in the 1st quarter. Contravisory Investment Management Inc. now owns 1,711 shares of the scientific and technical instruments company’s stock valued at $179,000 after purchasing an additional 847 shares during the period. Finally, Captrust Financial Advisors grew its position in Itron by 6.3% in the 4th quarter. Captrust Financial Advisors now owns 2,144 shares of the scientific and technical instruments company’s stock valued at $233,000 after purchasing an additional 128 shares during the period. Institutional investors and hedge funds own 96.19% of the company’s stock.

Insider Buying and Selling

In related news, SVP Donald L. Reeves III sold 547 shares of the business’s stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $125.31, for a total value of $68,544.57. Following the transaction, the senior vice president directly owned 19,604 shares of the company’s stock, valued at approximately $2,456,577.24. The trade was a 2.71% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP John F. Marcolini sold 565 shares of the business’s stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $125.31, for a total value of $70,800.15. Following the completion of the sale, the senior vice president owned 14,396 shares in the company, valued at $1,803,962.76. This represents a 3.78% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 12,073 shares of company stock worth $1,480,880 in the last ninety days. Corporate insiders own 1.45% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on ITRI. Johnson Rice downgraded shares of Itron from a “buy” rating to an “accumulate” rating in a research report on Friday, August 1st. Roth Capital lifted their price target on shares of Itron from $130.00 to $150.00 and gave the company a “buy” rating in a research report on Tuesday, July 22nd. JPMorgan Chase & Co. raised shares of Itron from a “neutral” rating to an “overweight” rating and lifted their price objective for the stock from $128.00 to $145.00 in a report on Thursday, July 31st. Guggenheim reaffirmed a “buy” rating and set a $155.00 price objective (up from $133.00) on shares of Itron in a report on Monday, July 14th. Finally, Stephens set a $130.00 price objective on shares of Itron in a report on Monday, August 4th. Ten equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, Itron has an average rating of “Moderate Buy” and a consensus target price of $136.55.

Itron Price Performance

Shares of NASDAQ:ITRI opened at $120.45 on Friday. The company’s 50-day moving average is $129.33 and its 200 day moving average is $116.62. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.75 and a current ratio of 2.04. The company has a market capitalization of $5.51 billion, a P/E ratio of 20.59, a price-to-earnings-growth ratio of 0.66 and a beta of 1.46. Itron, Inc. has a fifty-two week low of $90.11 and a fifty-two week high of $140.04.

Itron (NASDAQ:ITRI) last issued its quarterly earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 earnings per share for the quarter, topping analysts’ consensus estimates of $1.33 by $0.29. The company had revenue of $606.76 million for the quarter, compared to the consensus estimate of $610.36 million. Itron had a net margin of 11.05% and a return on equity of 19.69%. The firm’s quarterly revenue was down .4% on a year-over-year basis. During the same period in the previous year, the firm earned $1.21 EPS. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. On average, equities research analysts forecast that Itron, Inc. will post 5.33 earnings per share for the current year.

Itron Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.